Impinj at Sartorius PI Forum 2025: Revolutionizing Biopharmaceutical Manufacturing and Collaboration
- Sartorius will host the inaugural PI Forum in June 2025 to discuss process intensification in biopharmaceutical manufacturing.
- The forum aims to connect industry leaders and promote innovation in drug development through practical workshops and demonstrations.
- Sartorius emphasizes its commitment to transforming biomanufacturing by fostering sustainable practices and strategic partnerships at the event.
Transforming Biopharmaceutical Manufacturing: Sartorius PI Forum 2025
Sartorius, a key player in the life sciences and biopharmaceutical sectors, announces its inaugural Sartorius PI Forum set for June 24-26, 2025, at the Royal Sonesta Boston. This pivotal event aims to unite leaders and innovators in biomanufacturing to discuss process intensification (PI) for protein therapeutics and emerging modalities. With a program designed to foster collaboration and innovation, the forum will include presentations from industry experts, practical workshops, and live demonstrations of Sartorius' latest PI solutions. Maurice Phelan, President of Sartorius North America, emphasizes that the forum is centered on enabling real change within the biomanufacturing ecosystem, not merely discussing theoretical advancements.
The importance of process intensification in biopharmaceutical manufacturing cannot be overstated. Miriam Monge, Head of Customer & Industry Advocacy Strategy BPS at Sartorius, underscores that PI enhances speed, scale, and sustainability in drug development. By bridging the gap between strategic planning and practical execution, the forum aligns scientific advancements with technological innovations, ultimately shaping the future of therapy development. Participants can expect to gain actionable insights that focus on flexible manufacturing, automation, and digitalization—key components for achieving efficient and scalable production in the biopharmaceutical landscape.
By hosting the Sartorius PI Forum, the company reaffirms its commitment to transforming drug manufacturing through process intensification. The event serves as a platform for industry stakeholders to engage with cutting-edge technologies and trends that are likely to redefine biomanufacturing practices. Through these interactions, Sartorius aims to cultivate an environment conducive to innovation, connecting the right minds and resources to drive the future of biologics. This forward-thinking approach positions Sartorius as a leader in the industry, reinforcing its role in the evolution of biopharmaceutical manufacturing.
In addition to the main forum activities, attendees will have the opportunity to network with key stakeholders, fostering strategic partnerships that can lead to significant advancements in the field. The focus on sustainability and efficient manufacturing processes resonates with the industry's increasing demand for eco-friendly and cost-effective solutions. By prioritizing these discussions, Sartorius demonstrates its proactive stance in addressing the challenges faced by the biopharmaceutical sector today.
The Sartorius PI Forum not only highlights the company's leadership in biomanufacturing but also represents a crucial step in the ongoing evolution of drug development methodologies. By facilitating collaboration among industry experts and decision-makers, Sartorius is paving the way for innovative solutions that promise to enhance the future of healthcare.